NEDD9 protein supports growth of aggressive breast cancer

Oct 02, 2009

Researchers at Fox Chase Cancer Center have demonstrated that a protein called NEDD9 may be required for some of the most aggressive forms of breast cancer to grow. Their findings, based on the study of a mouse model of breast cancer, are presented in a recent issue of Cancer Research, available on-line now.

"For the first time, we have been able to present evidence that directly demonstrates reduced levels of NEDD9 in a living animal that limit the appearance of aggressive metastatic ," says co-author Erica A. Golemis, PhD, Fox Chase professor and co-leader of the Molecular Translational Medicine Program.

According to Golemis, the protein could serve as a , a molecule that could be detected to indicate the diagnoses of aggressive forms of breast cancer in the clinic. NEDD9 may also provide a target for some future therapeutic against metastatic cancer, Golemis says.

In 1996, the Golemis laboratory first identified NEDD9, a so-called scaffolding protein that forms part of a complex of molecules just inside the . NEDD9 and related proteins collectively act as transmitters, relaying signals from the cell surface to the cell interior to control cancer cell growth and movement. Over the past three years, scientists from laboratories around the world have contributed to a body of evidence showing how excess amounts of the NEDD9 contribute to metastasis in a number of cancers, including melanoma, lung cancer, and glioblastoma.

"One thought is that producing excess NEDD9 gives tumors a selective advantage over other cells," Golemis says, "so we are trying to determine how NEDD9 might provide that advantage."

To better understand the role of NEDD9 in breast cancer, the Fox Chase researchers studied a variety of , bred by colleagues at the University of Tokyo to lack the NEDD9 gene. These NEDD9 "knockout" mice were then made to turn on an oncogene that induces breast cancer in mice, and compared to normal mice given the same treatment. While the NEDD9 knockout mice developed breast cancers, they did so more slowly and less efficiently than normal mice, and without the activation of the central protein pathways most responsible for cancer growth and metastasis. In fact, mammary tumor growth in the showed marked genetic differences from the very moment premalignant lesions were detected, as compared to the normal mice.

"This was the first study able to address the question of what happens in breast cancer if this gene isn't around," Golemis says. "And the answer is that we see a more moderate cancer development, which alone speaks volumes on the role of the protein in aggressive breast tumors."

According to Golemis, the emerging body of research on NEDD9 shows that the protein forms an important node in the complex, interwoven pathways that dictate the fate of individual cells. These pathways regulate the entirety of a cell's life, from how select genes are transcribed to form new proteins to how a cell divides or even dies.

"By their nature, cancer cells are evolutionary machines, constantly looking for ways to exploit these vast networks of protein signaling pathways that are an inherent part of cell function," Golemis says. "The more we understand these pathways, the better we will understand the ways cancer cells evolve to use those pathways, and how to stop them."

Source: Fox Chase Cancer Center (news : web)

Explore further: Overweight linked to 500,000 cancer cases per year

add to favorites email to friend print save as pdf

Related Stories

Loss of cell's 'antenna' linked to cancer's development

Jun 28, 2007

Submarines have periscopes. Insects have antennae. And increasingly, biologists are finding that most normal vertebrate cells have cilia, small hair-like structures that protrude like antennae into the surrounding ...

'Bridge' protein spurs deadliest stages of breast cancer

Feb 22, 2007

A protein known for its ability to "bridge" interactions between other cellular proteins may spur metastasis in breast cancer, the disease’s deadliest stage, a study from Burnham Institute for Medical Research has found.

Herceptin targets breast cancer stem cells

Jul 09, 2008

A gene that is overexpressed in 20 percent of breast cancers increases the number of cancer stem cells, the cells that fuel a tumor's growth and spread, according to a new study from the University of Michigan Comprehensive ...

Recommended for you

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

E_L_Earnhardt
not rated yet Oct 03, 2009
No one has described the SUBSTANCE of a "gene", but if can break hydrogen bonds it can cause excellerated mitosis, (as does the high speed free
electron that usually triggers the event)!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.